Worth reading
42Recurring
Scored from 5 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
13.7
Year-on-year change in net sales (%)Wording
Conditional
How definitive the wording is.Results for this period
First quarter1 January 2026–31 March 2026ConsolidatedJapanese GAAPNet Sales9,963¥ millionYear on year +13.7%Progress 29.5%
Operating profit1,882¥ millionYear on year +27.3%Progress 49.5%
Ordinary income1,900¥ millionYear on year +40.2%Progress 51.4%
Net income attributable to owners of the parent1,293¥ millionYear on year +38.8%Progress 53.7%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥128.20
Financial position at period-end
Total assets40,070¥ million
of which net assets 20,984 ¥ millionEquity ratio 49.4%vs. prior year-end -1.0pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Regional salesDomestic Current fiscal year ¥2,919 million / Prior-year period ¥2,686 million / Overseas expansion Current fiscal year ¥7,044 million / Prior-year period ¥6,077 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥33,820 million (YoY +5.9%)
Operating profit¥3,800 million (YoY +10.1%)
Ordinary income¥3,700 million (YoY +3.3%)
Net income¥2,410 million (YoY +3.5%)
Annual Dividend Forecast¥60 → ¥60（0.0%）
Factors Behind Changes in Business Performance
In the agrochemicals business, sales of pest and disease control products remained strong both in Japan and overseas. Sales of fertilizers and biostimulant products were also strong in the fertilizers and biostimulants business.
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name No
Material subsequent eventsNo applicable matters.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥0 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥2 million
Depreciation and amortization¥313 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo
Issued Shares at Period-End11,072,000
Treasury Shares at Period-End985,167
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–31 March 2026 |
| Net Sales | ¥9,963 million (YoY +13.7%) |
| Operating profit | ¥1,882 million (YoY +27.3%) |
| Ordinary income | ¥1,900 million (YoY +40.2%) |
| Profit attributable to owners of the parent | ¥1,293 million (YoY +38.8%) |
| Net income per share | ¥128.20 |
| Equity ratio | End of the current fiscal period 49.4% / End of previous period 50.4% |
| Total assets | ¥40,070 million |
| Net assets | ¥20,984 million |
| Full-year earnings forecast | Net Sales ¥33,820 million (YoY +5.9%) / Operating profit ¥3,800 million (YoY +10.1%) / Ordinary income ¥3,700 million (YoY +3.3%) / Net income ¥2,410 million (YoY +3.5%) |
| Annual Dividend Forecast | ¥60 → ¥60（0.0%） |
| Regional sales | Domestic Current fiscal year ¥2,919 million / Prior-year period ¥2,686 million / Overseas expansion Current fiscal year ¥7,044 million / Prior-year period ¥6,077 million |
| Depreciation and amortization | ¥313 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥0 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥2 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name No |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 11,072,000 |
| Treasury Shares at Period-End | 985,167 |
| Factors Behind Changes in Business Performance | In the agrochemicals business, sales of pest and disease control products remained strong both in Japan and overseas. Sales of fertilizers and biostimulant products were also strong in the fertilizers and biostimulants business. |
Items this document does not state (12)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitOrders received and order backlogImpairment loss
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the agrochemicals business, sales of products including Hachihachi, Danisaraba, and Oncol remained strong. Sales of greenhouse fertilizers, fertigation fertilizers, and biostimulant products were also strong in the fertilizers and biostimulants business.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.